Key Takeaways
- Needham initiated Buy rating on ARM with $200 price target after maintaining Hold for over two years
- The company launched its first proprietary AGI CPU chip during its “Arm Everywhere” conference
- Meta Platforms became the inaugural customer for ARM’s new chip technology
- Jefferies increased price target to $210, projecting an additional $15B revenue opportunity through FY2031
- Latest quarterly results showed earnings per share of $0.43 versus $0.41 consensus, with 26.3% revenue growth year-over-year
Needham analysts shifted their stance on Arm Holdings to Buy this Wednesday, ending a neutral position maintained for over two and a half years and establishing a $200 price target for the next twelve months.
Arm Holdings plc American Depositary Shares, ARM
The brokerage highlighted ARM’s strategic evolution in the semiconductor space — implementing higher royalty structures, diversifying into subsystem offerings, and now manufacturing proprietary chips. According to Needham, these initiatives are beginning to yield tangible results.
ARM has delivered 26.45% revenue expansion across the trailing twelve-month period. A total of nineteen Wall Street analysts have adjusted their earnings projections upward for the coming quarter.
Central to Needham’s bullish thesis is ARM’s strategic entry into direct chip manufacturing via its partnership with Meta Platforms. Meta’s commitment as the inaugural customer for ARM’s proprietary AGI CPU provides immediate market validation and a prestigious commercial foundation.
The AGI CPU made its debut at ARM’s “Arm Everywhere” conference. Following the announcement, Jefferies analysts elevated their price target from $170 to $210, projecting the chip could contribute an incremental $15 billion in revenue by the end of fiscal 2031.
Barclays maintained its Overweight recommendation while raising its target from $165 to $200. Analysts at the firm emphasized the AGI CPU’s superior energy efficiency as a competitive differentiator for artificial intelligence computing tasks.
BofA Securities increased its target from $140 to $155 while maintaining a Neutral stance. Morgan Stanley preserved its Overweight recommendation with a $135 target, acknowledging ARM’s innovative dual-chiplet CPU architecture designed for cloud-based AI applications.
Wall Street Outlook
Current analyst consensus reflects a Moderate Buy rating, with the average price target landing at $168.17. This assessment incorporates 19 Buy recommendations, 6 Hold ratings, and 1 Sell rating.
ARM’s 50-day moving average currently registers at $120.72, while the 200-day moving average stands at $134.17. The shares trade within a 52-week band of $80.00 to $183.16, with a total market capitalization approaching $165.95 billion.
The company trades at a P/E multiple of 209. According to InvestingPro analysis, the shares appear overvalued compared to Fair Value calculations.
During the latest reporting period, ARM delivered earnings per share of $0.43, surpassing analyst expectations of $0.41. Total revenue reached $1.24 billion, representing a 26.3% increase versus the prior year and marginally exceeding the $1.23 billion Street estimate.
Forward Outlook
ARM’s management provided Q4 FY2026 earnings guidance ranging from $0.54 to $0.62 per share. The analyst community projects full-year EPS of $0.90.
Needham’s research emphasized the emergence of agentic artificial intelligence and the expanding importance of CPUs within AI data center infrastructure as sustained growth catalysts supporting ARM’s market position.
The AGI CPU targets agentic AI applications through a multi-core, energy-optimized architecture. Industry observers acknowledge the chip will require comprehensive software and hardware ecosystem development to effectively challenge established competitors such as Nvidia, Intel, and AMD.
Susquehanna upgraded ARM from Neutral to Positive in January, establishing a $150 price target. Mizuho reduced its target from $190 to $160 in February while retaining an Outperform rating.
Institutional investors currently hold 7.53% of outstanding shares.


